Clinical Trial Update: Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma [NA]

View source ↗

Summary

Mayo Clinic sponsors a clinical trial evaluating continuous glucose monitoring to manage hyperglycemia in patients with glioblastoma (IDH-wildtype, WHO Grade 4 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Idh-wildtype
• Who Glioma

Snippet

Sponsor: Mayo Clinic | Conditions: Glioblastoma, IDH-Wildtype, WHO Grade 4 Glioma | NA | Status: RECRUITING